iMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626

Clinical trial NCT03810898 · TERMINATED

Trial details

NCT number: NCT03810898
Sponsor: CHDI Foundation, Inc.
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2021-02-09
Primary completion: 2023-02-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.